ArticleJournal of experimental & clinical cancer research : CR2018

The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells.

Daniele Cretella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.